Publications
2025
Quaia R., Veronesi M., Anselmi M., Russo D., Penna I., Scarpelli R., Girotto S., Bertozzi F., Duca M., Bandiera T.
Development of fluorinated fragments into novel modulators of micro-RNA-21 levels
European School of Medicinal Chemistry – 44th Edition
Poster
Conference
2025
Anselmi M., Russo D., Penna I., Quaia R., Panosetti M., Scarpelli R., Girotto S., Veronesi M., Bertozzi F., Duca M., Bandiera T.
DISCOVERY OF NOVEL SMALL-MOLECULE MODULATORS OF microRNA-21 IN PANCREATIC CANCER CELLS
59th International Conference on Medicinal Chemistry
Poster
Conference
2025
Marotta G., Massenzio F., Ortega J., Russo D., Penna I., Falchi F., Babini G., Petralla S., Scarpelli R., Roggiolani E., Fricker G., Rosini M., Cavalli A., Monti B., Minarini A., Basagni F.
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors
Journal of Medicinal Chemistry, vol. 68, (no. 16), pp. 17130-17154
2025
Corno C., Russo D., Pignotti F., De Giorgi F., Penna I., Saccoliti F., Costantino M., Mirra L., Pettinari P., Carenini N., Corna E., Perta N., Ciniselli C.M., Pratesi P., Scarpelli R., Bertozzi F., Verderio P., Beretta G.L., Di Muccio G., Di Marino D., Bandiera T., Perego P.
Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors
Cancer Drug Resistance, vol. 8, (no. 50)
2025
Bertozzi F., Mazzarella M.A., Bottegoni G., Ricci F., Russo D., Penna I., Reggiani A., Bandiera T.
Multitarget-directed Ligands for Multiple Sclerosis with combined Anti-inflammatory and Remyelinating properties (MARs)
Congresso Scientifico Annuale Associazione Italiana Sclerosi Multipla e la sua Fondazione
Poster
Conference
2025
Coco G., Annese V.F., Galli V., Penna I., Russo D., Veronesi M., Scarpelli R., Sabella S., Caironi M.
Printed Integrated Logic Circuits Based on Chitosan-Gated Organic Transistors for Future Edible Systems
Advanced Functional Materials
2025
Di Martino R.M.C., Russo D., Penna I., Demuro S., Dalle Vedove A., Spagnuolo R., Ottonello G., Bertozzi S.M., Summa M., Desantis J., Valeri A., Pruccoli L., Tripathi S.K., Tarozzi A., Storici P., Girotto S., Bertorelli R., Armirotti A., Cruciani G., Bandiera T., Cavalli A., Bottegoni G.
Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies
European Journal of Medicinal Chemistry, vol. 297
2024
Quaia R., Veronesi M., Anselmi M., Russo D., Penna I., Scarpelli R., Girotto S., Duca M., Bertozzi F., Bandiera T.
Developmental of fluorinated fragments into novel modulators of micro-RNA-21 levels
RNA Technologies Flagship, 2nd Annual Retreat, Genova
Poster
Conference
2024
Quaia R., Anselmi M., Russo D., Penna I., Veronesi M., Bertozzi F., Duca M., Bandiera T.
DEVELOPMENT OF NOVEL FRAGMENTS INTO MODULATORS OF MicroRNA-21 LEVELS
European School of Medicinal Chemistry
Poster
Conference
2024
Anselmi M., Russo D., Penna I., Quaia R., Bellina F., Panosetti M., Scarpelli R., Veronesi M., Girotto S., Bertozzi F., Duca M., and Bandiera T.
DRUG DISCOVERY PLATFORM FOR THE IDENTIFICATION OF microRNA-21 SMALL-MOLECULE MODULATORS IN PANCREATIC CELLS
RNA Technologies Flagship, 2nd Annual Retreat, Genova
Poster
Conference
2024
Bertozzi F., Mazzarella M. A., Bottegoni G., Ricci F., Russo D., Penna I., Reggiani A., Bandiera T.
Multitarget-directed Ligands for Multiple Sclerosis with combined Anti-inflammatory and Remyelinating properties (MARs)
Congresso Scientifico Annuale Associazione Italiana Sclerosi Multipla e la sua Fondazione
Poster
Conference
2024
Quaia R., Anselmi M., Bertozzi F., Veronesi M., Russo D., Duca M., Bandiera T.
Small molecule modulators of the activity of microRNA-21
SCI 2024 - Chimica Elementi di futuro
Poster
Conference
2023
Demuro S., Di Martino R.M.C., Sauvey C., Tripathi S.K., Ortega J. A., Russo D., Penna I., Myers S. H., Bandiera T., Girotto S., Abagyan R., Cavalli A.
Design and synthesis of triple protein kinase inhibitors: paving the way towards novel CNS tools to reverse the aberrant tau phosphorylation
ACS Spring 2023 meeting
Poster
Conference
2022
Demuro S., Sauvey C., Tripathi S.K., Di Martino R.M.C., Shi D., Ortega J.A., Russo D., Balboni B., Giabbai B., Storici P., Girotto S., Abagyan R., Cavalli A.
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders
European Journal of Medicinal Chemistry, vol. 229
2022
Orioli R., Marotta G., Russo D., Penna I., Rosini M., Ortega J.A., Minarini A.
DESIGN AND SYNTHESIS OF AMMINOTIAZOLE DERIVATIVES AS DUAL LIGANDS TO GSK-3B AND FYN IN THE STUDY OF NEURODEGENERATIVE DISEASES
XXI Giornata della Chimica dell'Emilia Romagna (Bologna)
Poster
Conference